COFCO Biotechnology Co., Ltd. (SHE:000930)

COFCO Biotechnology Revenue

COFCO Biotechnology had revenue of 4.18B CNY in the quarter ending September 30, 2026, a decrease of -6.13%. This brings the company's total for the last twelve months to 16.62B, down -8.63% year-over-year. In the year 2025, COFCO Biotechnology had annual revenue of 17.51B, down -12.67%. That makes COFCO Biotechnology the 4,337th largest company in the world by revenue and 549th in China.

• Revenue (ttm): 16.62B
• Revenue Growth: -8.63%
• P/S Ratio: 0.54
• Revenue / Employee: 3.64M
• Employees: 4,571
• Market Cap: 8.89B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Agricultural Product Processing and Sales 17.24B 98.5%
• Unallocated Income from Other Operations 268.50M 1.5%

By Geography

Chart

• China 16.10B 91.9%
• Foreign 1.41B 8.1%

Fiscal year ended Dec 31, 2025 See the full COFCO Biotechnology breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	17.51B	-2.54B	-12.67%
Dec 31, 2024	20.05B	-325.59M	-1.60%
Dec 31, 2023	20.38B	460.90M	2.31%
Jan 1, 2023	19.92B	-3.64B	-15.46%
Jan 1, 2022	23.56B	3.65B	18.33%

Data Source: S&P Global Market Intelligence Last updated: Oct 23, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 4, 2026

Data Sources Report a data error